Treatment of <i>JAK2</i> V617F-positive primary myelofibrosis and advanced chronic myelogenous leukemia with ruxolitinib and flumatinib: a case report. [PDF]
Zhu F, Wang H, Qiu L.
europepmc +1 more source
Novel lysyl oxidase inhibitors attenuate hallmarks of primary myelofibrosis in mice
O. Leiva +8 more
semanticscholar +1 more source
CXCL8 and its cognate receptors CXCR1/CXCR2 in primary myelofibrosis. [PDF]
Vermeersch G +4 more
europepmc +1 more source
RUNX1::CBFA2T2 rearranged acute myeloid leukemia transformed from JAK2 V617F mutated primary myelofibrosis. [PDF]
Han L +4 more
europepmc +1 more source
Case report: Primary myelofibrosis presenting with portal hypertension mimicking cirrhosis. [PDF]
Gan X +7 more
europepmc +1 more source
Safety and efficacy of combined ruxolitinib and decitabine in accelerated and blast-phase myeloproliferative neoplasms [PDF]
Abboud, Camille N.
core +1 more source
Monocytosis is a powerful and independent predictor of inferior survival in primary myelofibrosis
A. Tefferi +10 more
semanticscholar +1 more source
Cardiac tamponade associated with primary myelofibrosis: a case report. [PDF]
Widodo WA +3 more
europepmc +1 more source
Primary myelofibrosis: 2017 update on diagnosis, riskāstratification, and management
A. Tefferi
semanticscholar +1 more source

